Background/Aims Ulcerative colitis (UC), along with Crohn’s disease, is one of the main types of inflammatory bowel disease (IBD). On the other hand, deregulated autophagy is involved in many chronic diseases, including IBD. In this study, we aimed to investigate the role of Atg5 and microRNA-181a (miR-181a) in the pathophysiology of UC.
Methods Colon biopsy, stool, and blood samples of 6 men and 9 women were confirmed for UC. Also, 13 men and 17 women were selected as healthy control (HC). Enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry were used to measure the Atg-5 content of the colon biopsies. Besides, the serum and stool levels of Atg5 were measured using ELISA. Moreover, the total RNA of blood cells was extracted and evaluated for the expression of miR-181a.
Results We found 1.2 ng/mL versus 0.46 ng/mL, 0.34 ng/mL versus 0.24 ng/mL, and 0.082 ng/mL versus 0.062 ng/mL of Atg5 in stool, intestinal tissue, and serum of UC and HCs, respectively. There was no significant difference in the expression of miR-181a in the blood samples of UC and HCs. Immunohistochemistry showed high positivity without any significant difference between the 2 groups in the quantitative analysis.
Conclusions The significant difference observed between the stool Atg5 content of the HCs and UC patients may provide new insight into using this protein as a diagnostic biomarker, however, considering the small size of our studied population further studies are needed.
Citations
Citations to this article as recorded by
Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date Alessandro Giammona, Bruno Giovanni Galuzzi, Elena Imperia, Clarissa Gervasoni, Sofia Remedia, Laura Restaneo, Martina Nespoli, Laura De Gara, Flaminia Tani, Michele Cicala, Michele Pier Luca Guarino, Danilo Porro, Antonio Cerasa, Alessia Lo Dico, Annamar International Journal of Molecular Sciences.2025; 26(1): 413. CrossRef
Circular RNAs in inflammatory bowel disease: a review of mechanisms, biomarkers and therapeutic potential Le Yang, Huahui Li, Min Tang, Lingnan He, Lijun Yang Frontiers in Immunology.2025;[Epub] CrossRef
Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits Jiao Zhou, Chunxia Li, Meng Lu, Gaoyue Jiang, Shanze Chen, Huihui Li, Kefeng Lu, Hans-Uwe Simon PLOS Biology.2024; 22(3): e3002537. CrossRef
Autophagy: A potential target for natural products in the treatment of ulcerative colitis Wei Zhang, Menglong Zou, Jia Fu, Yin Xu, Ying Zhu Biomedicine & Pharmacotherapy.2024; 176: 116891. CrossRef
Deficiency of Autophagy-Related Gene 5 in Keratinocytes Leads to Aggravation of Epidermal Damage in 2,4-Dinitrochlorobenzene-Induced Allergic Contact Dermatitis Yi-Qun Zhang, Ta Xiao, Chang-Jun Song, Yang-Ying Ke, Xiang Gao, Min Li, Heng Gu, Xu Chen International Journal of Dermatology and Venereology.2023; 6(4): 214. CrossRef
Personalized medicine in inflammatory bowel disease: Perspectives on Asia Su Hyun Park, Sang Hyoung Park Journal of Gastroenterology and Hepatology.2022; 37(8): 1434. CrossRef
Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs Soo-Young Na, You Sun Kim The Korean Journal of Internal Medicine.2022; 37(5): 906. CrossRef
A study on the potential role of autophagy‐related protein 10 as a biomarker for ulcerative colitis Fatemeh Abbasi Teshnizi, Nasrin Kazemipour, Saeed Nazifi, Kamran Bagheri Lankarani, Masood Sepehrimanesh, Iman Razeghian Jahromi Physiological Reports.2021;[Epub] CrossRef
Regulation of Endoplasmic Reticulum Stress-Autophagy: A Potential Therapeutic Target for Ulcerative Colitis Dan Qiao, Ziwei Zhang, Yali Zhang, Qian Chen, Yujun Chen, Yingjue Tang, Xiong Sun, Zhipeng Tang, Yancheng Dai Frontiers in Pharmacology.2021;[Epub] CrossRef